Identification of Novel <i>Trypanosoma cruzi</i> Cysteine Protease Inhibitors via Ligand-Based Virtual Screening of FDA-Approved Drugs with Trypanocidal Activity. [PDF]
Vázquez-Jiménez LK +12 more
europepmc +1 more source
Priority without progress: the FDA's neglected tropical disease voucher program after 18 years. [PDF]
Goh M, Outterson K, Kesselheim AS.
europepmc +1 more source
Induced pluripotent stem cell-derived human macrophages as an infection model for Trypanosoma cruzi. [PDF]
Baert L +5 more
europepmc +1 more source
Evaluation of the autonomic nervous system in autochthonous patients from Amazon with acute Chagas disease treated with benznidazole. [PDF]
Hosannah da Silva E Silva MR +12 more
europepmc +1 more source
Ruthenium Complexes Containing Thiobenzamide Act as Potent and Selective Anti-<i>Trypanosoma cruzi</i> Agents through Apoptotic Cell Death. [PDF]
das Neves MVG +11 more
europepmc +1 more source
Priced Out of Treatment: The Exorbitant Cost of Antiparasitic Drugs in the United States. [PDF]
Alperin C, Nguyen N, Duffey M, Clark EH.
europepmc +1 more source
Asymptomatic Trypanosoma cruzi Infection Identified During Blood Donation Screening. [PDF]
Ngo JM, Maknojiya AN, Patel RY, Meza A.
europepmc +1 more source
Transcriptomic and ultrastructural responses to Amiodarone-Itraconazole in naturally benznidazole-resistant and -susceptible Trypanosoma cruzi strains. [PDF]
Gutiérrez S +5 more
europepmc +1 more source
Synthesis and Antitrypanosomal Activity of Novel 2‑Nitroimidazole-3,5-Disubstituted Isoxazole Derivatives with Diaryl Ether and Thioether Substituents. [PDF]
Santos LBB +9 more
europepmc +1 more source
As the development of new drugs for Chagas disease is not a priority due to its neglected disease status, an option for increasing treatment adherence is to explore alternative treatment regimens, which may decrease the incidence of side effects. Therefore, we evaluated the efficacy of different therapeutic schemes with benznidazole (BNZ) on the acute ...
Fonseca, Kátia da Silva +10 more
openaire +1 more source

